The Evolving Clinical Spectrum of Diabetic Neuropathy
Saturday, June 24, at 3:15 p.m. PT
San Diego Convention Center
Presentation: Update on Mechanisms
Mark A. Yorek, PhD
Professor of Medicine,
University of Iowa
What is your presentation about?
I will present new information on the current mechanisms thought to contribute to development of diabetic peripheral neuropathy (DPN). There is no treatment for DPN and a better understanding of the etiology is needed to develop a treatment. Such treatment will likely require a combination of interventions.
What makes this topic important in 2023?
Diabetic peripheral neuropathy is the most prevalent of diabetes complications. It is the leading cause of non-trauma related amputations. A better understanding of its etiology is needed for determining an effective treatment.
How did you become involved with this area of diabetes research or care?
As a graduate student I was trained in carbohydrate metabolism and studied lipid metabolism as a postdoctoral student. This combination of studies was a normal transition into diabetes research.
How do you think your presentation will impact diabetes research or care?
The main point I hope attendees take away from my presentation is that an effective treatment for diabetic peripheral neuropathy will likely require a combination of pharmaceutical and life altering therapies.
What are you most looking forward to at the 83rd Scientific Sessions?
Research updates and meeting with colleagues.
Register to View the 83rd Scientific Sessions Virtual Program
Virtual registration is still an option to take advantage of the valuable content presented at the 83rd Scientific Sessions on the latest advances in diabetes research, prevention, and care. Access to the virtual program is available to registered participants June 27–August 28.